Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
150 participants
INTERVENTIONAL
2021-09-01
2028-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke
NCT00712179
Locomotor Training (Walking Therapy) Post Stroke
NCT00715299
Mechanisms of Walking Recovery After Stroke
NCT02858349
A Novel, Comprehensive Approach to Post-stroke Gait Rehabilitation
NCT04411303
Locomotor Recovery Following Traumatic Brain Injury
NCT04503473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These conflicting hypotheses likely arise from differences in terminology and methodology used to characterize recovery post-stroke. First, the traditional measure of neurological recovery (LL-FMA) does not adequately characterize other impairments (strength, postural stability) that are more closely associated to locomotor function and are responsive to physical interventions. Second, despite gains in selected impairments, patients often utilize alternative (compensatory) movement patterns to accomplish locomotor tasks. More directly, locomotor recovery (i.e., speed/distance) is often accomplished using strategies employed prior to stroke and compensatory strategies, particularly in those with substantial impairments.
Our central hypothesis is that if changes in neurological recovery are deterministic, other measures of locomotor recovery or compensations may also be predictable. Our published data detail how HIT or conventional interventions can alter impairments and locomotor recovery, as well as changes in locomotor compensations. More directly, our data provide evidence that specific subgroups of patients demonstrate substantial compensations with improved recovery, whereas others reveal limited changes despite similar interventions. Data that detail the progression of neurological recovery, locomotor recovery, and locomotor compensations throughout the subacute to chronic phase post-stroke and their responsiveness to HIT is uncertain. Similar to upper limb recovery algorithms, predictions of mobility outcomes could provide valuable information to clinicians who make decisions regarding patient's prognosis, including whether patients will be able to walk with or without assistance or at certain speeds, and what compensatory strategies they may require to ambulate independently (braces, devices or altered movement patterns). The overarching goal of this project is to examine the time course of neurological and locomotor recovery, and associated compensatory strategies, over the subacute to chronic stages post-stroke and their responsiveness to HIT.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1
Observational evaluations for 6 months followed by 3-4 months of high-intensity training (HIT)
high-intensity training focused on stepping in variable contexts
Approximately 10 weeks (\~30 sessions) of high-intensity training
Phase 2
Observational evaluations for 1 month followed by 3-4 months of high-intensity training (HIT)
high-intensity training focused on stepping in variable contexts
Approximately 10 weeks (\~30 sessions) of high-intensity training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high-intensity training focused on stepping in variable contexts
Approximately 10 weeks (\~30 sessions) of high-intensity training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first ever stroke
* unilateral hemiparesis
* currently receiving inpatient rehabilitation
* ability to follow 1-step commands
* provision of informed consent
* medical clearance from the rehabilitation physician to participate. \\
Exclusion Criteria
* absolute criteria for termination of exercise testing during initial and repeated ECG testing during graded exercise testing using ACSM guidelines .
* other orthopedic or neurological disorder that limited walking prior to stroke
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rehabilitation Hospital of Indiana
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
George Hornby
Professor of Physical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas G Hornby
Role: PRINCIPAL_INVESTIGATOR
Indiana University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehabilitation Hospital of Indiana
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IU2011618233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.